Author | Gerrit zur Hausen, MSc | OncLive

Author | Gerrit zur Hausen, MSc

Articles

Frontline Nab-Paclitaxel/Gemcitabine in Metastatic Pancreatic Cancer

September 29, 2016

Video

Gerrit zur Hausen, MSc, clinical trial manager, Epidemiologe, Institut für Klinisch-Onkologische Forschung, discusses a trial exploring frontline treatment with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic adenocarcinoma who have high-bilirubin levels.

x